Feng‐Chun Yang
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 1%
- Mesenchymal stem cell research
Papers in
-
- Epigenetics and DNA Methylation 12
- RNA Research and Splicing 8
- DNA Repair Mechanisms 8
- Hematology 46
- Acute Myeloid Leukemia Research 32
- Hematopoietic Stem Cell Transplantation 15
- Co-authors
- Mingjiang Xu (43 shared papers)D. Wade Clapp (13 shared papers)Karl Staser (11 shared papers)David A. Williams (7 shared papers)Jin Yuan (19 shared papers)David A. Ingram (16 shared papers)Chen‐Leng Cai (3 shared papers)Jiapeng Wang (2 shared papers)
- Journals
- Blood (31 papers)Human Molecular Genetics (6 papers)Journal of Clinical Investigation (6 papers)PLoS ONE (5 papers)Experimental Hematology (3 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Feng‐Chun Yang
129 papers receiving 5.5k citations
Feng‐Chun Yang's Hit Papers
Peers
Comparison fields: 5 of 124
- Hematology 1.2k
- Genetics 764
- Neurology 1.1k
- Immunology 1.1k
- Molecular Biology 2.8k
Countries citing papers authored by Feng‐Chun Yang
This map shows the geographic impact of Feng‐Chun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Chun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Chun Yang more than expected).
Fields of papers citing papers by Feng‐Chun Yang
This network shows the impact of papers produced by Feng‐Chun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Chun Yang. The network helps show where Feng‐Chun Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng‐Chun Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies Hit paper breakdown → | 2011 | 507 |
| 2 | Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. | 2000 | 262 |
| 3 | 2008 | 249 | |
| 4 | 2008 | 222 | |
| 5 | 2001 | 169 | |
| 6 | 2000 | 155 | |
| 7 | 1997 | 151 | |
| 8 | 2000 | 142 | |
| 9 | 1998 | 134 | |
| 10 | 2013 | 132 | |
| 11 | 2019 | 129 | |
| 12 | 2006 | 123 | |
| 13 | 2011 | 110 | |
| 14 | 2002 | 104 | |
| 15 | 2006 | 99 | |
| 16 | 2010 | 95 | |
| 17 | 2001 | 83 | |
| 18 | 2014 | 79 | |
| 19 | 2015 | 79 | |
| 20 | 2001 | 77 |
About Feng‐Chun Yang
Feng‐Chun Yang is a scholar working on Molecular Biology, Hematology, Neurology, Immunology and Oncology, having authored 131 papers that have together received 5.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (32 papers), Neurofibromatosis and Schwannoma Cases (27 papers), Hematopoietic Stem Cell Transplantation (15 papers), Epigenetics and DNA Methylation (12 papers), Sarcoma Diagnosis and Treatment (10 papers), Bone Tumor Diagnosis and Treatments (9 papers), RNA Research and Splicing (8 papers) and DNA Repair Mechanisms (8 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (764 citations), Neurology (1.1k citations), Immunology (1.1k citations) and Molecular Biology (2.8k citations). Feng‐Chun Yang has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Mingjiang Xu, D. Wade Clapp, Karl Staser, David A. Williams, Jin Yuan, David A. Ingram, Chen‐Leng Cai, Jiapeng Wang, Bruce Petersen and Xiaoqiang Cai. Their work appears in journals such as Blood, Human Molecular Genetics, Journal of Clinical Investigation, PLoS ONE and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.